11 dec: Insideres handel
11 dec: Delårsrapport 1.-3. kvartal 2017/18, Ændret strategisk fokus, Hur..
11-12-2017 13:07:46

Financial Calendar 2018

Relateret indhold
Relateret debat
13 jul - 
Njaaah, okay så 😊
13 jul - 
Det er  jo faktisk også det jeg skriver
13 jul - 
hofpeung - jeg forstår din tilgang, men tingene k..

 

February 8, 2018

 

Quiet period prior to the annual report begins (4 weeks)

March 2, 2018

 

Deadline for shareholder proposals for the AGM

March 8, 2018

 

Annual report for 2017

April 13, 2018    

 

Annual General Meeting

April 19, 2018

 

Quiet period prior to the Interim report begins (2 weeks)

May 3, 2018

 

Interim report - 3 months 2018

August 2, 2018

 

Quiet period prior to the Interim report begins (2 weeks)

August 16, 2018

 

Interim report - 6 months 2018

October 25, 2018

 

Quiet period prior to the Interim report begins (2 weeks)

November 8, 2018

 

Interim report - 9 months 2018

 

For further information, please contact:

Gry Husby Larsen, General Counsel

Peter M. Eriksen, CEO

Telephone +45 4529 0000, e-mail investor@bioporto.com

About BioPorto

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.

 

 

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
12 jul
BIOPOR
Så er der under 20 dage (10 børsdage) tilbage til de skal indsende deres FDA bliver spændende og se ..
1

Fondsbørsmeddelelser

#

EuroInvestor: I fokus
#

#

EuroInvestor: I fokus
#

#

EuroInvestor: I fokus
#

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/UBS: Indleder med købsanbefaling og ser aktien stige 37 pct.
2
Novo/ABM: Recepttal understøtter forventning om opjustering
3
Genmab/Jefferies: Darzalex øger tilliden til ledelsens forventninger
4
Aktier/tendens: Genmab og kolleger får udlandsnyt i let nervøs åbning
5
Aktier/åbning: Vestas fører an i positivt C25-indeks

Relaterede aktiekurser

BioPorto A/S 3,150 0,5% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Seneste nyheder


Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. juli 2018 02:55:35
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180712.1 - EUROWEB3 - 2018-07-18 02:55:35 - 2018-07-18 02:55:35 - 1 - Website: OKAY